Patients' experiences attributed to the use of Passiflora incarnata: A qualitative, phenomenological study.


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 29 03 2018
revised: 12 11 2018
accepted: 13 11 2018
pubmed: 18 11 2018
medline: 26 2 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Passiflora incarnata Linnaeus (Passiflora incarnata) was established as a medicinal plant in Europe in the middle of the 19th century. Since then, it has been used for the treatment of anxiety, sleep disorders and restlessness in Western European phytotherapy. This study provides insights into how Passiflora incarnata is currently used and experienced as a medicinal plant by German-speaking patients in Switzerland. This qualitative study aimed to explore patients' experiences and the values, views and interpretive processes that formed their perceptions of the use of an ethanolic extract of Passiflora incarnata. A total of 8 patients participated in this exploratory, qualitative observational study. The patients filled in pre- and posttreatment questionnaires, kept diaries and were interviewed in a face-to-face setting. For the data analysis, descriptive statistics, qualitative content analysis, narrative inquiry and documentary methods were applied. This is the first qualitative study of patients' real-life experiences with an ethanolic extract of Passiflora incarnata. We identified three distinct types of patient biographical narratives attributed to different experiences when using Passiflora incarnata. Patients with type 1 narratives described moving from a performance orientation to resetting priorities and attaining calmness. Patients with type 2 narratives maintained a performance orientation while adopting calmness. Patients with type 3 narratives maintained a performance orientation and suffered from persistent illness. The distinct biographical narratives of the patients associated with their specific experiences of taking Passiflora incarnata provide an additional perspective on the use of Passiflora incarnata as a medicinal plant.

Identifiants

pubmed: 30447340
pii: S0378-8741(18)31030-4
doi: 10.1016/j.jep.2018.11.022
pii:
doi:

Substances chimiques

Anti-Anxiety Agents 0
Hypnotics and Sedatives 0
Plant Extracts 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-301

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Claudia Canella (C)

Institute for Complementary and Integrative Medicine, University Hospital Zurich, Switzerland and University of Zurich, Switzerland. Electronic address: claudia.canella@usz.ch.

Christoph Bachmann (C)

Hirschmatt Apotheke, Hirschmattstr. 46, 6003 Lucerne, Switzerland.

Balz Wolfensberger (B)

Institute of Education, University of Zurich, Switzerland.

Claudia M Witt (CM)

Institute for Complementary and Integrative Medicine, University Hospital Zurich, Switzerland and University of Zurich, Switzerland; Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Germany; Center for Integrative Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH